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Abstract
Magnetic resonance (MR) imaging plays an important 
role in the diagnosis and staging of acute and chronic 
pancreatitis and may represent the best imaging te­
chnique in the setting of pancreatitis due to its un­
matched soft tissue contrast resolution as well as non­
ionizing nature and higher safety profile of intravascular 
contrast media, making it particularly valuable in radio­
sensitive populations such as pregnant patients, and 
patients with recurrent pancreatitis requiring multiple 
follow­up examinations. Additional advantages include 
the ability to detect early forms of chronic pancreatitis 
and to better differentiate adenocarcinoma from focal 
chronic pancreatitis. This review addresses new trends 
in clinical pancreatic MR imaging emphasizing its role 
in imaging all types of acute and chronic pancreatitis, 
pancreatitis complications and other important differen­
tial diagnoses that mimic pancreatitis. 
© 2014 Baishideng Publishing Group Inc. All rights reserved.
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Core tip: Magnetic resonance (MR) imaging is widely 
used in the diagnosis and staging of pancreatitis, and 
may represent the best imaging techniques due to its 
unmatched soft tissue contrast resolution, non­ionizing 
nature, higher safety profile of intravascular contrast 
media. This review addresses new trends in clinical 
pancreatic MR imaging emphasizing its role in imaging 
all types of acute and chronic pancreatitis, autoimmune 
pancreatitis, pancreatitis complications, and other im­
portant differential diagnoses that mimic pancreatitis.
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INTRODUCTION
Pancreatitis is a major cause for abdominal pain and hos-
pitalization in the United States and worldwide. Incidence 
of  pancreatitis is increasing in the recent decades[1,2]. Im-
aging plays a central role in the management and compli-
cations of  pancreatitis[3]. The recent development of  new 
respiratory gating techniques, motion resistant pulse se-
quences, and additive advantages of  magnetic resonance 
cholangiopancreatography (MRCP) imaging protocols 
make magnetic resonance imaging (MRI) a very accurate 
investigation modality for assessing patients with pancre-
atitis[4,5], particularly acutely ill patients unable to breath 
hold[6]. This review addresses new trends in clinical pan-
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creatic MR imaging emphasizing its role in imaging all 
types of  acute and chronic pancreatitis, pancreatitis com-
plications and other important differential diagnoses that 
mimic pancreatitis. 
MRI and MRCP are the most safe, effective, and 
noninvasive imaging method for evaluation of  the 
pancreas and ductal system[7]. Technical innovations in 
MRI such as the use of  phased-array coils and parallel 
imaging allow for improved spatial resolution and faster 
acquisition times. The use of  triggering techniques[8] or 
motion resistant sequences such as free-breathing three-
dimensional gradient-echo with radial data sampling 
(Radial 3D-GRE), make routine MRI of  the pancreas 
more feasible[6]. MRI has the unique capability of  allow-
ing noninvasive evaluation of  the pancreatic parenchyma, 
pancreatic ductal system, peripancreatic soft tissue, and 
vascular network in a single examination. The concurrent 
use of  Secretin improved the diagnostic yield of  MRCP 
in the evaluation of  the pancreatic duct integrity and pan-
creatic exocrine function in cases of  early pancreatitis[9-11].
Normal pancreatic parenchyma has high aqueous 
protein content that results in high signal intensity on 
T1-weighted fat-suppressed breath-hold gradient-echo 
sequences[12] and shows uniform enhancement on the 
hepatic arterial-dominant phase, also known as late he-
patic arterial phase (Figure 1). The standard MR protocol 
includes a fat-suppressed 3D-GRE T1-weighted pre- and 
post-gadolinium imaging in the capillary phase (hepatic 
arterial-dominant phase), portal, and interstitial phase 
(3-10 min post-Gadolinium)[13]. The main advantages of  
these sequences are being able to acquire thinner sections 
(3 mm) and acquire multiplanar imaging. On gadolinium-
enhanced images, the pancreas demonstrates a uniform 
capillary blush on immediate post-Gadolinium images, 
which renders it markedly higher in signal intensity 
than liver, neighboring bowel, and adjacent fat[14]. By 
1-min post-Gadolinium, the pancreas shows approxi-
mately isointense signal to fat on non fat-suppressed T1-
weighted GRE, and moderately higher signal than back-
ground fat in fat-suppressed SGE or 3D-GE sequences.
Echo-train spin-echo sequences such as T2-weighted 
half-Fourier acquisition snapshot turbo spin-echo 
(HASTE) are motion robust sequences that provide a 
sharp anatomic delineation of  the common bile duct 
(CBD) on coronal plane images and of  the main pancre-
atic duct on transverse plane images. Also, T2-weighted 
images provide information on the complexity of  the 
fluid within pancreatic pseudocysts, which may reflect 
the presence of  complications such as necrotic debris or 
infection. 
MRI combining T1, T2, early and late post-gadolin-
ium images, MRCP, and MRA generate comprehensive 
information on the pancreas[13,15].
Three-dimensional MRCP images are acquired in the 
plane of  the pancreatic duct in an oblique coronal projec-
tion with the additive advantage of  yielding multiplanar 
maximal projection (MIP) and volume rendering (VR) 
imaging (Figure 2). It delineates longer segments of  the 
pancreatic duct in continuity[13,16].
PANCREATITIS
Pancreatitis is defined as the inflammation of  the pancre-
as and considered the most common pancreatic disease 
in children and adults. It can be acute; representing an 
acute inflammatory process of  the pancreas, or chronic; 
progressing slowly with continued, permanent inflamma-
tory injury to the pancreas.
Acute pancreatitis
Acute pancreatitis is an acute inflammatory process of  
the pancreas, which may spread to adjacent tissues and 
organs[17,18]. It can be triggered by several factors, of  
which alcoholism and choledocholithiasis are responsible 
for 90% of  cases in the United States[17]. The diagnosis 
of  non-complicated acute pancreatitis mainly depends 
on elevated serum amylase or lipase level of  more than 
three time of  its upper limit with characteristic clinical 
findings[18,19]. In severe forms of  the disease, imaging is 
performed to assess pancreatic parenchyma perfusion, 
the extent of  necrosis as well as the presence and extent 
of  fluid collections and other complications.
The revised Atlanta classification for acute pancreatitis 
in 2012[20] was aimed to establish international standards 
of  definitions of  acute pancreatitis and its complications 
and to ensure the proper communication between multi-
disciplinary team working in these patients[20]. According 
to this classification early imaging will only be required 
when patient is suspected to have pancreatitis without 
elevated serum amylase or lipase.
Classification of acute pancreatitis
According to the revised Atlanta classification, acute 
pancreatitis can be divided into interstitial edematous and 
necrotizing pancreatitis[20].
Interstitial edematous pancreatitis
It is commonly present as a generalized enlargement 
of  pancreas, or in some cases, as focal swelling due to 
inflammatory edema of  the pancreas and surrounding 
peripancreatic fat (Figure 3) and relatively homogenous 
enhancement with contrast (Figure 4). Some peripan-
creatic fluid may also be present (Figure 5). The clinical 
symptoms of  interstitial edematous pancreatitis usually 
resolve within first week of  onset of  disease[21].
Necrotizing pancreatitis
About 5%-10% of  cases develop necrosis of  pancreatic 
tissue, peripancreatic fat, or both (Figure 6).
Development of  pancreatic and peripancreatic ne-
crosis due to the impaired perfusion in acute pancreatitis 
takes several days[22,23]; explaining why initial imaging may 
underestimate disease progression. Initial images may 
show patchy non-enhancing areas that become more con-
fluent or diffuse with time[22,23] (Figure 7). Non-enhancing 
areas after 7 d of  the disease are diagnosed as paren-
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chymal necrosis[24]. Normal enhancement of  pancreatic 
parenchyma may be seen in peripancreatic necrosis, and 
is associated with increased rate of  morbidity than in 
patients with interstitial edematous pancreatitis[21,22,25]. 
Pancreatic and peripancreatic necrosis can be infected, 
liquefied, remain solid, sterile or in some cases persist or 
disappear with time.
Complications of acute pancreatitis
According to the revised Atlanta classification[20] for pancre-
atitis, the following are the complications noted on imaging.
Acute peripancreatic fluid collections: They occur early 
in the course of  the disease[20,26]. They present between the 
facial planes surrounding the pancreas and do not have 
clear wall around them. They can be single or multiple, 
but their contents are typically homogenous and sterile. 
Patients with Acute peripancreatic fluid collection (APFC) 
are asymptomatic and treatment is unnecessary. Most 
of  these collections resolve on their own[26,27]. If  they do 
not resolve within a month, they may become pancreatic 
pseudocysts (Figure 8).
Pancreatic pseudocysts: Cystic lesions with homog-
enous internal fluid content, but without any solid 
materials, demarcated by a clear wall and located in the 
pancreatic or peripancreatic regions are called pseudo-
cysts (Figures 9 and 10). High amylase levels are seen in 
aspirated fluid from these cysts[20].
Pancreatic pseudocysts develop due to the leakage of  
pancreatic juice from the ruptured main pancreatic duct 
or its side branches of  more than 4 wk, with no obvious 
pancreatic necrosis. T2-weighted images confirm the ab-
sence of  solid content in the collection. Pseudocysts may 
also arise in the setting of  acute necrotizing pancreatitis 
as a result of  a “disconnected duct syndrome” where 
proximal pancreatic parenchymal necrosis isolates a still 
viable distal pancreatic parenchymal remnant[28].
Pseudocysts may be evident many weeks following 
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Figure 1  Normal pancreatic appearance on magnetic resonance imaging. A: Axial single-shot turbo spin-echo T2-weighted (HASTE) image with fat-suppression; 
B: Axial pre-contrast 3D-GRE T1-weighted image with fat-suppression. Axial post-Gadolinium 3D-GRE T1-weighted image with fat-suppression during the hepatic 
arterial-dominant (C) and hepatic-venous phases (D). The pancreas demonstrates low T2 signal intensity (A) and high T1 signal intensity on pre-contrast images (B) 
reflecting high protein content of the exocrine gland. The pancreas demonstrates maximal enhancement on hepatic arterial-dominant phase (C); which fades on sub-
sequent phases; reflecting a normal capillary blush. 
Figure 2  Normal magnetic resonance cholangiopancreatogram. Coronal 
oblique thick-slab magnetic resonance cholangiopancreatogram (MRCP) im-
age. There is normal course and normal uniform diameter of the pancreatic (ar-
row) and extra-hepatic biliary ducts (arrowhead). This sequence requires less 
than 1 s to acquire and is very sensitive for detecting stones. 
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ducts disruption, and occasionally they can get infected[20]. 
Because of  CT’s low contrast resolution, MRI may be 
indicated in the early course of  the disease to differenti-
ate ANCs from APFCs. With time, parenchymal necrosis 
becomes more obvious, which aids in the distinction of  
ANCs from APFCs. MRI is more sensitive in depicting 
solid tissue within ANCs.
Walled-off  necrosis: Well-defined necrotic tissues sur-
rounded by enhancing viable inflammatory walls are 
referred to as walled-off  necrosis (WONs). They can 
be confined to the pancreatic parenchyma, involve the 
operative necrosectomy secondary to localized leakage of  
the disconnected duct into the necrosectomy cavity.
Acute necrotic collections: Well-defined collections of  
variable amount of  necrotic materials and fluid within a 
month of  disease occurrence are referred to as acute ne-
crotic collections (ANCs) (Figure 11). They can be single 
or multiple, and are sometimes multi-loculated. The main 
differences between ANCs and APFCs are that ANCs 
contain necrotic materials, and also develop from necro-
tizing pancreatitis, sometimes associated with pancreatic 
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Figure 3  Mild acute interstitial edematous pancreatitis. A: Axial single-shot 
turbo spin-echo T2-weighted (HASTE) image; B: Axial pre-contrast 3D-GRE 
T1-weighted images with fat-suppression; C: Axial post-Gadolinium 3D-GRE 
T1-weighted images with fat-suppression during the hepatic arterial-dominant 
phases. There is mild lace-like increased T2 signal involving the pancreatic paren-
chyma, associated with effacement of the distal pancreatic duct (arrowhead), due 
to surrounding edema, and minimal amount of peripancreatic fluid around (arrows) 
the head and body (A). The pancreas demonstrates mildly enlarged distal body 
and tail (A-C); with diffuse minimally decreased T1 signal intensity (B); and mild 
heterogeneous enhancement of the distal body and tail on the hepatic arterial-
dominant phase (C) in keeping with diffuse edematous pancreatitis.
Figure 4  Gallstone acute interstitial edematous pancreatitis. A: Axial single-
shot turbo spin-echo T2-weighted (HASTE) image with fat-suppression; B: Axial 
in-phase T1-weighted image; C: Axial post-Gadolinium 3D-GRE T1-weighted 
image with fat-suppression during the hepatic arterial-dominant phase. There is 
mild diffuse lace-like increased T2 signal involving the pancreatic parenchyma 
(arrowheads), associated with a small amount of peripancreatic fluid (arrows) 
(A). The pancreas demonstrates diffuse minimal decreased T1 signal intensity 
with peripancreatic stranding (B); in addition to minimally reduced homogenous 
enhancement (C) in keeping in with diffuse edematous pancreatitis. There are 
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peripancreatic tissue (Figure 12), or even at times be away 
from the pancreas. The whole process may take about a 
month after the onset of  necrotizing pancreatitis. WONs 
can be sterile or infected as well as solitary or multiple[20]. 
Contrast-enhanced CT may misdiagnose WONs as pseu-
docysts. MRI may be useful to differentiate solid from 
liquid contents within the lesion. Identification of  ductal 
disruptions is necessary for further management.
Infected pancreatic necrosis: The diagnosis of  infected 
pancreatic necrosis is suspected in the presence of  extra-
luminal gas or gas-fluid level in the areas of  pancreatic 
or peripancreatic necrosis on imaging[20] (Figure 13). The 
amount of  gas-fluid level depends on the stage of  the 
disease. Confirmation of  diagnosis is made by micros-
copy and culture of  fine needle aspiration[29,30]. Infected 
necrosis is associated with high morbidity and mortality 
and requires drainage and antibiotic therapy.
Disconnected pancreatic duct syndrome: It is char-
acterized by disruption of  the main pancreatic duct with 
loss of  continuity between the pancreatic duct and the 
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Figure 5  Acute interstitial edematous pancreatitis with acute peripancreatic fluid collection. A: Axial single-shot turbo spin-echo T2-weighted (HASTE) image 
with fat-suppression; B: Axial 3D-GRE T1-weighted image with fat-suppression. The pancreas shows mild lace-like increased T2 signal involving the pancreatic pa-
renchyma (A), with minimally decreased T1 signal intensity and mild peripancreatic stranding (B), associated with peripancreatic fluid collections (arrowheads, A) and 
small proteinaceous fluid at the left anterior para- and peri-renal spaces (arrows); both associated with imperceptible wall in keeping with acute interstitial edematous 
pancreatitis and acute peripancreatic fluid collection. Minimal ascites is also seen (A). 
Figure 6  Pancreatic and peripancreatic necrosis. A: Axial single-shot turbo spin-echo T2-weighted (HASTE) image with fat-suppression. Axial post-Gadolinium 
3D-GRE T1-weighted image with fat-suppression during the B hepatic arterial-dominant and C hepatic-venous phases. The pancreas shows very heterogeneous 
increased T2 signal (asterisk) (A) and no appreciable enhancement on the post-Gadolinium images (arrowheads) (B, C); associated with a large peripancreatic fluid 
collection (arrow) (A-C) and a thick enhancing rim on delayed images (C) in keeping with pancreatic and peripancreatic necrosis.
Figure 7  Necrotizing pancreatitis. A: Axial T1-weighted fast low-angle shot (FLASH) image with fat-suppression; B: Axial post-Gadolinium 3D-GRE T1-weighted 
image with fat-suppression during the hepatic arterial-dominant phase. The pancreas shows diffuse decreased T1 signal intensity (A) with patchy areas of minimal 
enhancement (arrowheads) (B) in keeping with necrotizing pancreatitis.
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gastrointestinal tract caused by ductal necrosis after se-
vere acute necrotizing pancreatitis treated by percutane-
ous drainage or necrosectomy[20,28].
Diagnosis of  disconnected pancreatic duct syndrome 
is important in the determination of  the optimal ap-
proach (surgical, endoscopic, and percutaneous) for 
patients with organizing pancreatic necrosis or fluid col-
lections[31]. The treatment of  the disconnected pancreatic 
duct is surgical and requires either internal drainage or 
distal pancreatic resection for complete resolution. The 
exact incidence of  this syndrome remains unknown; 
however, pancreatic duct disruption has been observed 
in as many as 50% of  patients after an episode of  severe 
acute necrotizing pancreatitis[9,31].
The morbidity associated with ERCP in the setting 
of  recent acute pancreatitis is high, and the procedure is 




Figure 8  Gallstone acute edematous pancreatitis with acute peripancreatic fluid collection. A: Axial single-shot turbo spin-echo T2-weighted (HASTE) image 
with fat-suppression; B: Axial post-Gadolinium 3D-GRE T1-weighted image with fat-suppression. There is diffuse lace-like increased T2 signal involving the pancreatic 
parenchyma (A), minimally reduced enhancement post-Gadolinium, peripancreatic stranding, and thick rim of enhancement (arrowheads) surrounding the pancreas (B), 
associated with peripancreatic fluid collection (arrows) in keeping with diffuse edematous pancreatitis and peripancreatic acute peripancreatic fluid collection. There 
are also innumerable gallstones (asterisk) (A).
Figure 9  Large pancreatic pseudocyst. A: Axial single-shot turbo spin-echo T2-weighted (HASTE) image with fat-suppression; B: Axial pre-contrast 3D-GRE T1-
weighted image with fat-suppression. Axial post-Gadolinium 3D-GRE T1-weighted image with fat-suppression during (C) the true late hepatic arterial and (D) hepatic-
venous phases. There is a large oval shaped thin walled cyst (asterisks) with homogenously increased T2 (A) and decreased T1 signal intensities (B) at the left 
subdiaphragmatic region, with dependent non-enhancing (C) layering material (arrows) (A, B). The cyst demonstrates mild wall enhancement (C, D) in keeping with a 
large pancreatic pseudocyst. There is also diffuse pancreatic parenchyma thinning, irregular diffuse main pancreatic ducal dilatation (arrowhead), and pancreatic side-
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often technically challenging because of  ongoing edema 
that involves the duodenum or complete disruption of  
the main pancreatic duct. MRCP is a non-invasive way 
of  assessing the disconnected pancreatic duct syndrome 
(DPDS), where discrete intra pancreatic fluid collection 
along the expected course of  the main pancreatic duct, 
with viable upstream pancreatic parenchyma, is sugges-
tive of  the diagnosis of  the disconnected pancreatic duct 
syndrome[9].
ERCP findings of  ductal obstruction at the level of  
this fluid collection, with or without extravasation of  con-
trast material, help in confirming this diagnosis. Although 
ERCP is still considered the reference standard for the 
evaluation of  disconnected pancreatic duct syndrome, 
secretin-enhanced MRCP can be useful in determining 
whether the main pancreatic duct is disrupted or discon-
nected in patients with necrotizing pancreatitis[9,11,32-34] 
(Figure 13).
Other complication: Other local complications of  acute 
pancreatitis include gastric outlet dysfunction, splenic or 
portal veins thrombosis, and large bowel necrosis. Clini-
cal features of  local complications includes recurrent 
abdominal pain, secondary increase in serum amylase, 
impaired renal and liver function, fever, and, leukocytosis.
MRI and MRCP in acute pancreatitis
A variety of  pulse sequences are routinely used in pan-
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Figure 10  Multiple intrapancreatic pseudocysts. Coronal (A) and axial (B) single-shot turbo spin-echo T2-weighted (HASTE) image with fat-suppression; C: Axial 
post-Gadolinium 3D-GRE T1-weighted image with fat-suppression during the hepatic arterial-dominant phase. There are multiple thin walled cysts, some of which 
show multi-loculation (asterisks) (A) within the pancreatic parenchyma extending into the lesser sac and porta hepatis (A-C) and demonstrate mild uniform wall en-
hancement (arrowheads) (C) in keeping with multiple pseudocysts.
Figure 11  Acute necrotic collection. A, B: Axial single-shot turbo spin-echo T2-weighted (HASTE) image; C: Axial fast low-angle shot (FLASH) in-phase T1-
weighted image; D: Axial FLASH in-phase T1-weighted image with fat-suppression; E: Axial post-Gadolinium 3D-GRE T1-weighted image with fat-suppression during 
the hepatic arterial-dominant phase. There is a well-defined fluid collection (arrows) replacing a great portion of the pancreatic parenchyma and extending into the 
peripancreatic tissue, associated with few internal areas of decreased T2 signal intensity (arrowheads) (A); which do not show any appreciable enhancement (B, C) in 
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Figure 12  Necrotizing pancreatitis with peripancreatic walled-off necrosis. A: Axial single-shot turbo spin-echo T2-weighted (HASTE) image. Axial (B) pre- and 
post-Gadolinium 3D-GRE T1-weighted images with fat-suppression during the hepatic arterial-dominant (C) and hepatic-venous phases (D). There is a well-defined 
fluid collection (arrows) at the region of the pancreatic body/tail (A, B); which demonstrates a uniform mildly enhancing thickened rim (arrowheads) (C,D) and contains 
a dependent non-enhancing debris (asterisk) (C, D) in keeping with necrotizing pancreatitis and walled-off necrosis.
Figure 13  Infected peripancreatic fluid and interrupted duct syndrome in a patient with acute pancreatitis. A: Axial single-shot turbo spin-echo T2-weighted 
(HASTE) image with fat-suppression. Axial pre- (B) and post- (C) Gadolinium 3D-GRE T1-weighted images with fat-suppression during the hepatic arterial-dominant 
phase; D: Axial post-Gadolinium radial 3D-GRE T1-weighted images with fat-suppression during the interstitial phase. There is a large irregular multiloculated (partially 
visualized) peripancreatic collection. It demonstrates decreased T2 (A) and T1 (B) signal with a thick rim of increased T2 signal (arrows) (A) that shows enhancement 
on delayed images (arrows, C, D) in keeping with infected necrotic collection (proven by fine needle aspiration). There is also a well-defined fluid collection in the 
lesser sac (asterisk) (A) with an enhancing thin wall (D) and minimal ascites (arrowheads, A). Of note is the motion robustness of the radial 3D-GRE (D) compared to 
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creatic imaging including T1- and T2-weighted sequences 
with or without fat-suppression and 3D-GRE T1-
weighted pre- and post-gadolinium administration. MRCP 
is routinely added to the standard imaging protocol to as-
sess ductal obstruction, dilation, anatomical variation (Fig-
ure 14), or complication such as disconnected pancreatic 
duct syndrome. In selected cases, secretin-enhanced MRCP 
further increases the diagnostic value of  MRCP[9,11,32-34]. 
T2-weighted fat-suppressed images are extremely sensitive 
in detecting subtle, early pancreatitis in patients who have 
negative CT scan findings[19]. It has been reported that MR 
severity index (MRSI) assessed by using 0.5 Tesla (T) MR 
systems without contrast significantly correlated with CT 
severity index (CTSI), Ranson score, C-reactive protein 
levels, appearance of  systemic complications, duration of  
hospitalization, and clinical outcome[35,36].
CHRONIC PANCREATITIS
Chronic pancreatitis is defined as continuing inflam-
matory destruction of  pancreatic tissue that results in 
irreversible structural changes of  pancreas including 
parenchymal tissue and ductal system. The incidence of  
chronic pancreatitis is 5-12 per 100000 persons per year; 
accounting for more than 120000 outpatient visits and 
50000 hospitalizations annually[37]. Alcohol consumption 
is a major cause in adults (80%) in developed countries, 
whereas malnutrition is the most common cause world-
wide[38]. Other causes of  chronic pancreatitis includes 
genetic mutations, pancreatic ductal obstruction or ana-
tomical variation, hypercalcemia, nutritional factors, hy-
perparathyroidism, and hyperlipidemia.
Diagnosis is made by clinical history, testing of  pan-
creatic exocrine function, and imaging[39]. MRI is more 
reliable in diagnosing chronic pancreatitis than CT or 
ultrasonography[40]. MRI will identify parenchymal atro-
phy, duct dilation, and pancreatic ductal and parenchymal 
changes after hormonal stimulation[40,41]. Chronic pancre-
atitis damages the acinar cells, main pancreatic duct, and 
side branches. Microscopic finding includes sclerosis and 
fibrosis of  pancreatic duct and side branches, acinar cell 
atrophy and ductal dilatation stricture or stenosis. Eosin-
ophilic protein plugs or intraductal calcification may be 
seen with the ducts. All these changes will lead to focal, 
segmental or generalized atrophy or loss of  pancreatic 
tissue, main and/or side pancreatic ducts stenosis, stric-
ture or dilatation[40-44].
Early chronic pancreatitis
Parenchymal changes might be preceded by ductal chang-
es in chronic pancreatitis[45]; this makes MRCP alone 
more advantageous in suspected early chronic pancreati-
tis. MRI detects not only morphological characteristics, 
but also early fibrotic changes. Fibrosis is shown by di-
14768 October 28, 2014|Volume 20|Issue 40|WJG|www.wjgnet.com
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Figure 14  Mild pancreatitis complicated by pancreatic divisum and santorinicele. A: Axial single-shot turbo spin-echo T2-weighted (HASTE) image with fat-
suppression. Axial pre- (B) and post- (C) Gadolinium radial 3D-GRE T1-weighted image with fat-suppression during the hepatic-venous phase; D: Coronal oblique 
thick-slab magnetic resonance cholangiopancreatogram image. There is mild lace-like increased T2 signal involving the pancreatic parenchyma, associated with a 
minimal amount of peripancreatic fluid (A) and pachy pancreatic enhancement on post-Gadolinium images (B, C) in keeping with mild acute pancreatitis. There is also 
abnormal course and insertion of the main pancreatic duct into the minor papilla (D) terminating in a small cystic structure (arrow) in keeping with pancreatic divisum 
and a small Santorinicele (D).
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minished signal intensity on fat-suppressed T1-weighted 
images and diminished parenchymal enhancement on 
immediate post-Gadolinium images[46] (Figure 15). Low 
signal intensity on fat-suppressed T1-weighted images 
reflects loss of  the aqueous protein within the pancreatic 
acini. Diminished pancreatic parenchymal enhancement 
on the capillary phase images reflects disruption of  the 
normal capillary bed and increased chronic inflammation 
and fibrosis. MRCP findings in early chronic pancreatitis 
often demonstrate normal main pancreatic duct with 
dilated and irregular side duct branches (Figure 16). The 
limiting factor is the underestimation of  ductal size. Some 
investigators reported that patients with abnormal MR 
imaging findings but normal MRCP might benefit from 
dynamic secretin-MRCP (S-MRCP), which may reveal 
ductal abnormalities due to improved visualization oth-
erwise not detected on MRCP alone[45]. Secretin-MRCP 
has been reported to show ductal changes, like dilatations 
and strictures in early chronic pancreatitis.
Late chronic pancreatitis
All patients with late or advanced chronic pancreatitis 
show diminished signal intensity of  the pancreas on T1-
weighted fat-suppressed images, an abnormally low per-
centage of  contrast enhancement on arterial phase images, 
and progressive parenchymal enhancement on the 5-min 
delayed post-Gadolinium images; reflecting the pattern of  
enhancement of  fibrous tissue[47,48]. MRCP in advanced 
phase demonstrates dilatation of  the main pancreatic duct 
with ectasia of  the side branches; giving chain of  lakes 
appearance (Figure 17) manifested as pancreatic ductal 
strictures, irregularities and intra ductal calculi, appearing 
as hypointense filling defects. Other findings include intra 
ductal calcifications, which are the most specific finding, 
seen in nearly half  of  the patients with chronic pancre-
atitis and parenchymal atrophy (Figure 18), though it is 
neither specific nor sensitive as it is seen normally with 
aging. Intraductal or parenchymal calcifications are usually 
seen with alcohol related chronic pancreatitis but not on 
chronic pancreatitis resultant from other causes.
Pancreatic inflammatory mass vs pancreatic cancer 
Chronic inflammatory process in chronic pancreatitis can 
produce a focal mass lesion, especially in the head of  the 
pancreas that can mimic more sinister pathologies i.e., 
pancreatic adenocarcinoma[49] (Figure 19).
Both chronic pancreatitis and adenocarcinoma show 
similar imaging characteristics on MRI due to abundant 
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Figure 15  Chronic pancreatitis. A: Axial post-Gadolinium 3D-GRE T1-weighted image with fat-suppression during the hepatic arterial-dominant phase; B: Axial 
post-Gadolinium FLASH in-phase T1-weighted image with fat-suppression during the hepatic-venous phases. The pancreatic body and tail show poor early contrast 
enhancement (A) and mild enhancement on the delayed images related to fibrosis (B) in keeping with chronic pancreatitis.
Figure 16  Mild chronic pancreatitis. A: Coronal oblique thick-slab magnetic cholangiopancreatogram image; B: Coronal single-shot turbo spin-echo T2-weighted 
(HASTE) image with fat-suppression. There is uniform dilatation of the pancreatic duct (arrow) and prominence of the pancreatic duct side-branches (arrowheads), 
without significant diffuse thinning of the pancreatic parenchyma (A, B) in keeping with mild chronic pancreatitis. 
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fibrosis and ductal obstruction; therefore, making the dif-
ferentiation between these two entities very difficult. Both 
are generally seen as mildly hypointense on T1-weighted 
images and heterogeneously mildly hyperintense signal 
on T2-weighted images. Other possible similar findings in 
both conditions include common bile duct and main pan-
creatic duct dilation (double duct sign), stricture of  ducts, 
peripancreatic fat stranding due to infiltration, vascular 
encasement of  superior mesenteric artery, and splenic 
vein thrombosis[50,51]. T1- and T2-weighted images alone 
cannot differentiate both conditions. The following sup-
porting feature may favor inflammatory origin: part of  
the duct seen through the mass is not dilated and shows 
smooth tapering (duct penetrating sign)[52]. Features fa-
voring carcinoma include abrupt cut off  of  pancreatic 
duct just proximal to the ampulla, pancreatic atrophy 
distal to the mass, and increased duct caliber-to-gland 
ratio (ductal diameter is out of  proportion to pancreatic 
parenchymal thickness). Pancreatic adenocarcinoma can 
develop in patients with chronic pancreatitis, which fur-
ther limits the diagnostic capability of  imaging necessitate 
histological confirmation[51,53]. Excessive fibrosis seen 
in both conditions explains the similarities on imaging. 
Because of  the similarities between these conditions on 
clinical and imaging evaluations, histology is mandatory 
for final diagnosis[50].
Complications of chronic pancreatitis
The most common non-neoplastic complications of  
chronic pancreatitis include pseudocysts, pseudoaneu-
rysms (due to erosion of  the arterial wall), splenic vein 
thrombosis with subsequent development of  collaterals, 
biliary obstruction (due to pseudocysts), and gastrointes-
tinal complications; such as gastric outlet obstruction or 
bowel ischemia[19,54]. These complications are well depict-
ed with MRI. MRI with MRCP may be superior to CT in 
detecting specific complications like pseudocysts, fistula 
formation, and distal common biliary dilatation. Vascular 
complications associated with higher morbidity and mor-
tality.
MRI and MRCP in chronic pancreatitis
MRI, combined with MRCP, is an excellent modality to 
assess patients with clinically suspected chronic pancre-
atitis[40], MRI evaluates ductal alterations and obstructive 
causes of  chronic pancreatitis like ductal calculi. MRI 
also assesses signal changes of  gland, glandular vol-
ume depletion or atrophy, and pancreatic perfusion on 
contrast-enhanced images. Volume depletion manifests 
as reduction of  anterior posterior diameter of  pancreas 
in the entire gland or in specific segments. Pancreatic fi-
brosis causes reduction of  pancreatic signal intensity on 
MRI. The normal pancreas is high in signal intensity on 
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Figure 17  Chronic pancreatitis. Coronal oblique maximal intensity projection 
image of a 3D magnetic cholangiopancreatogram image. There is mild pancre-
atic main ductal (arrow) and side branches (arrowheads) dilatation in keeping 
with chronic pancreatitis.
Figure 18  Chronic pancreatitis. A: Axial single-shot turbo spin-echo T2-
weighted (HASTE) image. Axial pre- (B) and post- (C) Gadolinium 3D-GRE 
T1-weighted image with fat-suppression during the hepatic arterial-dominant 
phase. There is evidence of diffuse atrophy of the pancreatic parenchyma with 
mild uniform pancreatic ductal dilatation (arrow) and pancreatic side-branches 
prominence (A), associated with diminished T1 signal intensity (B) and minimal 
arterial enhancement (C) in keeping with chronic pancreatitis. There are also 
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fat-suppressed T1-weighted images due to the presence 
of  aqueous protein in the acini. Normally, the pancreas 
shows a uniform capillary blush on the late arterial phase 
images and fades on the subsequent hepatic venous and 
delayed images. In patients with chronic pancreatitis, loss 
of  aqueous protein in the acini causes reduction of  sig-
nal on fat-suppressed T1-weighted images. The pancreas 
shows progressive enhancement that peaks on the portal 
venous or interstitial phase. This finding is the result of  
pancreatic fibrosis that causes impairment of  capillary 
blood flow to the gland. A time-related perfusion model 
can assess pattern of  enhancement of  the pancreas, 
where normal pancreas shows high upslope in contrast. 
In cases of  chronic pancreatitis, a plateau-like pattern 
is observed. Periductal fibrosis causes dilated main and 
side pancreatic ducts due to traction[40,41,43,55,56]. Several 
classification systems are used to define and characterize 
the severity of  chronic pancreatitis. The Cambridge clas-
sification, which is the most commonly used grading sys-
tem for chronic pancreatitis, was established in 1984 for 
ERCP[57]. This system classifies pancreatograms into nor-
mal or equivocal, mild, moderate, and severe changes of  
chronic pancreatitis on the basis of  the main pancreatic 
duct dilatation, side-branch dilatation, and additional fea-
tures (Table 1). The new MR techniques with addition of  
secretin make it possible to use Cambridge classification 
for MRCP as well by increasing ductal filling to improve 
the depiction of  the pancreatic ductal system[9,11,56,58-60].
Secretin-enhanced MRCP
Secretin-enhanced MRCP is an imaging modality that 
not only helps identify the characteristic ductal changes 
of  acute or chronic pancreatitis but also provides an 
estimate of  pancreatic excretory volume. It is important 
to remember that the presence of  normal duodenal fill-
ing does not exclude impairment of  pancreatic exocrine 
function, which is measured by determining the fluid 
bicarbonate level[11,61]. Secretin is a polypeptide hormone 
made by 27 amino acids, secreted by the duodenum. Af-
ter meals, acid secretion increases in duodenum stimulat-
ing the secretion of  secretin. Secretin stimulates the pan-
creas; which secretes bicarbonate rich fluid and increases 
the tone of  sphincter of  Oddi. The main pancreatic duct 
distends by the accumulation of  the pancreatic juice due 
to the effect of  secretin. The distention will be maximal 
in about four to ten minutes. Ductal anatomy can be 
clearly studied after secretin stimulation. Other advan-
tages of  secretin are ease of  administration and safety 
of  use with low incidence of  major side effects[9,11,61-63]. 
Excretory function of  the pancreas is graded in secretin-
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Figure 19  Chronic inflammatory mass simulating pancreatic adenocar-
cinoma. A: Axial T2-weighted image with fat-suppression; B: Pre-contrast 3D-
GRE T1-weighted image with fat-suppression during the hepatic arterial dominant 
phase; C: Post-contrast 3D-GRE T1-weighted image with fat-suppression during 
the hepatic arterial dominant phase. There is a complex lobulated pancreatic 
head mass (arrowheads) with multiple foci of increased T2 signal throughout 
(arrows) (A), associated with decreased pancreatic parenchymal T1 signal (B), 
proximal pancreatic ductal dilation (not shown), and diminished enhancement on 
post-Gadolinium images (C) in keeping the diagnosis of focal chronic pancreatitis.
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A Table 1  Evaluation criteria for magnetic resonance imaging 
and magnetic resonance cholangiopancreatography according 
to Cambridge classification 
Cambridge 0 None
Cambridge 1 Not identifiable MRCP abnormalities
Cambridge 2 Two or more of the following abnormalities: 
   Pancreatic duct 2 to 4 mm in the body of the pancreas
   Mild pancreatic enlargement
   Heterogeneous parenchymal structure
   Small cysts (< 10 mm)
   Duct irregularities
   More than 3 abnormal side branches
Cambridge 3 All the abnormalities listed in 2, above, along with 
abnormal main duct (> 4 mm)
Cambridge 4 One of the abnormalities listed in 2 or 3, above, and 
one or more of the following: 
   Cystic structures > 10 mm
   Parenchymal calcifications
   Intraductal filling defects (calcium stones)
   Duct obstruction (stricture)
   Major irregularity of duct
MRCP: Magnetic resonance cholangiopancreatography.
Manikkavasakar S et al . Magnetic resonance imaging of pancreatitis
enhanced MRCP according to the duodenal anatomic im-
aging findings: grade 1, when pancreatic fluid is confined 
to the duodenal bulb; grade 2, when fluid is seen as far 
as the second part of  the duodenum; and grade 3, when 
duodenal filling reaches the third part of  the duodenum. 
Diminished estimated pancreatic exocrine function is sus-
pected in the absence of  duodenal fluid accumulation, or 
with grade 1 duodenal filling[11,61]. This grading does not 
differentiate between early and established pancreatitis. 
To adequately assess the exocrine response to secretin, 
patients should be fasting for at least 4 h before the MR 
imaging examination. It is recommend that the adminis-
tration of  a negative oral contrast agent to remove high 
signal intensity from the fluid within the stomach and 
duodenum on MRCP images. Ferumoxsil suspension 
(300 mL) can be used as an oral contrast agent. Other 
oral contrast agent is diluted gadolinium-DTPA (5 mL 
gadolinium DTPA diluted with 75 mL of  distilled water). 
Oral contrast agents shorten the T2 time and act like a 
negative T2 agent[55,64-67]. If  a commercial product is not 
available, pineapple juice or blueberry juice can be used as 
alternative negative MR contrast material. Oral contrast 
agent should be given 30 min before the procedure to 
counteract signals from preexisting duodenal secretions. 
Secretin bolus injection can cause abdominal cramps; 
to avoid this, slow intravenous infusion over a minute is 
indicated. Following negative oral contrast administration 
and intravenous infusion of  0.2 µg secretin, serial coronal 
single-shot fast spin echo images are obtained every 30 s 
for 15 min from the time of  injection[44,45,67,68].
Diffusion weighted imaging and chronic pancreatitis
Diffusion weighted imaging (DWI) sequence may be used 
to assess pancreatic parenchymal atrophy in patients with 
chronic pancreatitis, where atrophy and ductal pathology 
are subtle, and has shown results comparable to MRI and 
MRCP[48,69]. DWI assesses the random microscopic mo-
tion of  water protons to obtain the apparent diffusion 
coefficient (ADC). This is reflected by reduction in ADC 
values in case of  chronic pancreatitis as loss of  exocrine 
functional tissue of  pancreas increases the amount of  
fibrosis, leading to reduction in water diffusibility[40,60]. 
Furthermore, when DWI is used in combination with 
secretin stimulation, the diffusion coefficients have either 
delayed or lower peak values in chronic pancreatitis, indi-
cating reduced exocrine function[48,70,71].
Special types of chronic pancreatitis
Autoimmune pancreatitis: Continuous inflammatory 
process of  the pancreas due to an autoimmune patho-
genesis leading to chronic pancreatitis called autoimmune 
pancreatitis. Other autoimmune diseases associated with 
autoimmune pancreatitis (AIP) include ulcerative colitis, 
primary sclerosing cholangitis, primary biliary cirrhosis, 
retroperitoneal fibrosis, Sjogren’s syndrome, and systemic 
lupus erythematosus[72]. It is accounts for 2%-6% of  
chronic pancreatitis[73,74]. It is characterized, clinically, by 
obstructive jaundice (with or without pancreatic mass); 
histologically, by a lymphoplasmacytic infiltrate and 
fibrosis; and, therapeutically, by a dramatic response to 
steroids[75]. Early diagnosis of  AIP is critical as it often 
responds well to steroid therapy; thus avoiding complica-
tions.
There are three types based on morphological pat-
terns: diffuse, focal, and multifocal. Diffuse disease is the 
most common type. MRI commonly shows a swollen, 
sausage-like pancreas (Figure 20) with poorly demon-
strated borders, moderately decreased T1 signal intensity, 
mildly high T2 signal intensity, and delayed gadolinium 
enhancement of  the pancreatic parenchyma on post-gad-
olinium images. Additional findings that may be observed 
in AIP include low signal capsule-like rim surrounding 
the diseased parenchyma on T2-weighted images, delayed 
post-gadolinium enhancement[76], absence of  parenchy-
mal atrophy, ductal dilatation proximal to the site of  ste-
nosis, absence of  peripancreatic fluid, and clear demar-
cation of  the abnormality[77]. The diffuse form of  AIP 
may mimic diffuse disorders like lymphoma, metastases 
or other diffuse infiltrative processes however, in most 
of  these disorders, the parenchyma is heterogeneous and 
shows irregular contour.
Focal disease is less common and manifests as a well-
defined T2 hyperintense mass with a T2 hypointense cap-
sule-like rim surrounding the diseased parenchyma which 
may show delayed post-gadolinium enhancement, often 
involving the head and mimicking pancreatic adenocarci-
noma but most often without associated pancreatic duc-
tal cutoff. The characteristic imaging finding in MRCP 
is focal, segmental or diffuse stenosis or irregularity of  
main pancreatic duct.
The most commonly involved segment is the intra 
pancreatic common bile duct, accompanied by a lesser 
degree of  upstream dilatation of  the main pancreatic 
duct. Less frequently, multifocal intrahepatic biliary stric-
tures are also noted in AIP[78].
Groove/paraduodenal pancreatitis: Groove or para-
duodenal pancreatitis is an uncommon type of  focal 
chronic pancreatitis; which may affect the groove be-
tween the head of  the pancreas, the duodenum, and the 
common bile duct. The rest of  the pancreatic paren-
chyma is slightly compromised or spared[79,80]. Groove 
pancreatitis is categorized into 2 forms: pure, involving 
exclusively the groove; or segmental (Figure 21), in-
volving the groove and extending in to the pancreatic 
head[80]. Pathogenesis remains controversial but may 
result from obstruction of  the accessory pancreatic duct 
as it drains into the second portion of  the duodenum 
through the minor papilla[81]. It may be due the previous 
biliary diseases, gastric resections, peptic ulcer disease, 
true duodenal wall or pancreatic head cysts, or pancre-
atic head heterotopias in the duodenum[80,82]. Both pure 
and segmental form can cause progressive stenosis of  
the pancreatic duct, leading subsequently to diffuse 
chronic pancreatitis. The histopathologic hallmark of  
groove pancreatitis is the presence of  fibrosis and scar 
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Figure 20  Autoimmune pancreatitis. A: Axial single-shot turbo spin-echo T2-weighted (HASTE) image with fat-suppression; B: Axial T1-weighted image. Post-
Gadolinium 3D-GRE T1-weighted images with fat-suppression during the hepatic arterial-dominant (C) and hepatic-venous phases (D). There is evidence of diffuse 
pancreatic swelling with patchy mildly increased T2 signal (arrowheads) (A), decreased T1 signal (B), loss of the normal pancreatic lobulations, and diffuse obliteration 
of the pancreatic duct (arrow) (A); associated with patchy decreased early enhancement (C) and progression of enhancement on subsequent phases (D) in keeping 
with autoimmune pancreatitis.
Figure 21  Segmental form groove pancreatitis. Coronal (A) and axial (B) single-shot turbo spin-echo T2-weighted (HASTE) images with fat-suppression. Axial 
post-Gadolinium 3D-GRE T1-weighted images with fat-suppression during the hepatic arterial-dominant (C) and interstitial phases (D). There is mild duodenal thicken-
ing and edema (arrowheads) (A, B) associated with a sheet-like mass in the pancreaticoduodenal groove that extends to the pancreatic head and demonstrates de-
creased T1 signal pre-contrast (not shown), slightly decreased T2 signal with tiny cystic changes (white arrows) (A, B), early arterial hypo-enhancement (black arrow) (C) 
and progressive enhancement on the subsequent delayed images (D) due to fibrosis, in keeping with segmental form groove pancreatitis.
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tissue within the pancreaticoduodenal groove, in the 
pure form; or within the groove and superior portion of  
the pancreatic head, in the pure form of  the disease. The 
most relevant differential diagnosis of  groove pancreati-
tis, particularly in its segmental form, is pancreatic head 
adenocarcinoma.
The most characteristic finding on MRI is a sheet like 
mass between the head of  pancreas and duodenal C-loop. 
The mass demonstrates low signal on T1-weighted im-
ages compared to the rest of  the pancreatic parenchymal 
tissue, and variable signal on T2-weighted images. This 
variation in the T2 signal can be attributed to the time 
of  onset of  the disease; as subacute form of  the disease 
shows brighter signal on T2-weighted images due to 
edema, while chronic form of  the disease has a lower T2 
signal due to fibrosis[82]. Gadolinium-enhanced dynamic 
images show delayed and progressive heterogeneous 
enhancement, reflecting the fibrous nature of  the tissue. 
Cystic lesions can also be well seen on T2-weighted im-
ages in the groove or duodenal wall[80].
It may be challenging to differentiate groove pancre-
atitis from pancreatic head duct adenocarcinoma. Re-
cently, it was shown that by using three strict diagnostic 
criteria for groove pancreatitis: (1) focal thickening of  the 
second part of  the duodenum; (2) abnormal increased 
enhancement of  the second part of  the duodenum; and 
(3) cystic changes in the region of  the pancreatic accesso-
ry duct, distinction from pancreatic duct adenocarcinoma 
could be achieved with high diagnostic accuracy (87.2% 
of  patients), and a diagnosis of  cancer could be excluded 
with a negative predictive value of  92.9%[83].
Hereditary pancreatitis: Hereditary pancreatitis is an au-
tosomal dominant disease presenting as multiple episodes 
of  pancreatitis in the absence of  any predisposing fac-
tors and is consider as a premalignant disease[84]. Imaging 
findings include parenchymal and intraductal calcifica-
tions and parenchymal atrophy. However, in hereditary 
pancreatitis, imaging plays an important role to rule out 
structural causes of  pancreatitis and to closely monitor 
the development of  pancreatic cancer, the risk of  which 
is increased by many folds in these patients.
NEW TECHNIQUES
Continuous development in MRI technologies have re-
sulted in new techniques with increased signal-to-noise 
ratio, shorter breath-hold scan time and respiratory trig-
gering techniques to produce improved image quality and 
diagnostic performances. Edelman et al[85] reported that 
there is a marked improvement in SNR at 3 T compared 
with 1.5 T (by a factor of  2 in some cases) when using 
identical imaging parameters to image the pancreas. A 
recent study showed that respiratory-triggered 3D-MRCP 
using a navigator technique was feasible in routine clini-
cal practice. The navigator technique improved the image 
quality and lesion visualization of  free-breathing 3D-
MRCP compared with conventional respiratory triggering 
techniques using bellows (bellows technique)[86].
Imaging patients unable to hold their breath is chal-
lenging. Elderly or very sick patients, who are often part 
of  the pancreatitis population, cannot adequately hold 
their breath for the required time to acquire T1-weighted 
images. Radial 3D-GRE delivers robust contrast-enhanced 
imaging for these patients by being resistant to motion 
artifacts. A previous study by Bamrungchart et al[6] has 
shown that free-breathing radial 3D-GRE is of  value for 
pancreatic MR imaging in patients who are unable to sus-
pend respiration.
MR spectroscopy with non-invasive in-vivo assess-
ment of  metabolite concentrations has been applied in 
a variety of  different tissues (brain, prostate, breast, and 
liver). Hence, spectroscopy of  the pancreas has the po-
tential to offer a more accurate tissue characterization[48]. 
Despite this, Su et al[87] characterized the normal pancreas 
at 3.0 T and identified metabolites such as lipid, choline 
and cholesterol. Cho et al[88] used MR spectroscopy to 
distinguish between patients with chronic focal pancre-
atitis and patients with pancreatic carcinoma and found 
fewer lipids in pancreatitis than in pancreatic carcinoma. 
Furthermore, other studies also detected differences 
between normal pancreatic tissue and carcinoma tis-
sue with alterations in lipid, choline and fatty acids[89,90]. 
However, to the best of  our knowledge, this technique 
has not yet been applied in the characterization of  pa-
tients with pancreatitis.
CONCLUSION
In this review we emphasized the role of  MRI in imaging 
all types of  acute and chronic pancreatitis, pancreatitis 
complications, and other important differential diagno-
ses that mimic pancreatitis. MRI is a valuable alternative 
modality, with at least equal diagnostic performance to 
CT for the diagnosis and follow-up of  acute and chronic 
pancreatitis. The recent development of  new respiratory 
gating techniques, motion resistant pulse sequences, and 
additive advantages of  MRCP imaging protocols make 
MRI a very accurate investigation modality for assessing 
patients with pancreatitis; particularly acutely ill patients 
unable to breath hold. MRI is a non-ionizing cross sec-
tional imaging method with a safer intravenous contrast 
profile. This is particularly important in patients with 
acute pancreatitis, who often have a concomitant renal 
impairment of  some degree and often require repeated 
follow-up imaging. Additionally, MRI offers higher sen-
sitivity for the diagnosis of  subtle early changes of  acute 
pancreatitis (i.e., interstitial pancreatitis and peripancreatic 
edema) and early manifestations of  chronic pancreatitis.
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